It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Cancer-secreted exosomes are critical mediators of cancer-host crosstalk. In the present study, we showed the delivery of miR-21-5p from colorectal cancer (CRC) cells to endothelial cells via exosomes increased the amount of miR-21-5p in recipient cells. MiR-21-5p suppressed Krev interaction trapped protein 1 (KRIT1) in recipient HUVECs and subsequently activated β-catenin signaling pathway and increased their downstream targets VEGFa and Ccnd1, which consequently promoted angiogenesis and vascular permeability in CRC. A strong inverse correlation between miR-21-5p and KRIT1 expression levels was observed in CRC-adjacent vessels. Furthermore, miR-21-5p expression in circulating exosomes was markedly higher in CRC patients than in healthy donors. Thus, our data suggest that exosomal miR-21-5p is involved in angiogenesis and vascular permeability in CRC and may be used as a potential new therapeutic target.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details

1 Dongguan People’s Hospital affiliated to Southern Medical University, Department of Pathology, Dongguan, China (GRID:grid.284723.8) (ISNI:0000 0000 8877 7471); Guangdong Medical University, Department of Pathology, Dongguan, China (GRID:grid.410560.6) (ISNI:0000 0004 1760 3078)
2 Longhua District Maternity and Child Healthcare Hospital, Department of Obstetrics, Shenzhen, China (GRID:grid.410560.6)
3 Dongguan People’s Hospital affiliated to Southern Medical University, Department of Pathology, Dongguan, China (GRID:grid.284723.8) (ISNI:0000 0000 8877 7471)
4 Dongguan People’s Hospital affiliated to Southern Medical University, Department of science and education, Dongguan, China (GRID:grid.284723.8) (ISNI:0000 0000 8877 7471)
5 Guangdong Medical University, Department of Pathology, Dongguan, China (GRID:grid.410560.6) (ISNI:0000 0004 1760 3078)
6 Dongguan People’s Hospital affiliated to Southern Medical University, Department of Ultrasound, Dongguan, China (GRID:grid.284723.8) (ISNI:0000 0000 8877 7471)